Valneva, a European Biotech Leader in Vaccines and Antibodies

We are a biotech company in infectious diseases with two marketed products. Valneva covers the full value chain from bench to market. Vaccines against Japanese encephalitis and Cholera.

OVERVIEW

This domain valneva.com presently has a traffic classification of seven hundred and fifty thousand seven hundred and seventy-nine (the smaller the more traffic). We have evaluated two pages within the website valneva.com and found twenty-six websites interfacing with valneva.com. We were able to acquire three contacts and directions for valneva.com to help you communicate with them. We were able to acquire three mass communication sites retained by valneva.com. This domain valneva.com has been online for six hundred and thirty-nine weeks, three days, seventeen hours, and one minute.
Traffic Rank
#750779
Pages Analyzed
2
Links to this site
26
Contacts
3
Locations
3
Social Links
3
Online Since
Dec 2012

VALNEVA.COM RANKINGS

This domain valneva.com is seeing alternating quantities of traffic for the whole of the year. Against all odds, the web page had a ranking in the past twenty-four hours of seven hundred and fifty thousand seven hundred and seventy-nine.
Traffic for valneva.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for valneva.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for valneva.com

Date Range

All time
This Year
Last Year
Last Month

VALNEVA.COM HISTORY

This domain valneva.com was first recorded on December 07, 2012. This website was updated on the date of March 25, 2013. This web site will expire on the date of December 07, 2014. It is currently six hundred and thirty-nine weeks, three days, seventeen hours, and one minute young.
REGISTERED
December
2012
UPDATED
March
2013
EXPIRED
December
2014

SITE LENGTH OF LIFE

12
YEARS
3
MONTHS
5
DAYS

LINKS TO BUSINESS

Biomay Home

Results of BM32 Clinical Trials. Analytical Capacities and Quality Control. Results of BM32 Clinical Trials. Discovery, research and development of innovative allergy therapeutics. The privately held company pioneers the diagnostic and therapeutic use of recombinant allergens. We expect that follow-on treatment with BM32 in subsequent years will require only very few injections and will be very similar to your annual flu shot. Obviously, we will .

SITE NAMEHomepageGrimaud

Strengths to support your growth. Strengths to meet day-to-day challenges. Know more about it? Propulsé par E-majine.

Novogen - Homepage

Subscribe to our E-Newsletter! NOVOGEN present at the second edition. PAMED - Tunisia - May 2018. Newsletter Edition 13 January 2018. 5, rue des Compagnons. Subscribe to receive our newsletter.

Home Pfenex Innovative solutions for global health

We are a clinical stage development and licensing biotechnology company focused on leveraging our. Pfenex Expression Technology platform to develop and improve protein therapies for unmet patient needs. Learn about Pfenex Expression Technology and our other state of the art production capabilities. Learn about our advanced pipeline of therapeutic equivalents, vaccines, biologics, and biosimilars.

Accueil. Fondation ProGreffe.

En lien constant avec les patients, ils collaborent étroitement avec les chercheurs. La greffe leur offre une nouvelle qualité de vie, au lieu des contraintes de la dialyse.

VBC Seminars

Displaying next 6 VBC Regular Seminars ordered by date . Birth, life and death of a plant epidermal stem cell lineage. Dominique Bergmann - Stanford University. Karl Friston - Wellcome Trust Centre for Neuroimaging at UCL. The neural basis of speed, accuracy and confidence in a decision. Michael Shadlen - Columbia University.

Thuja Capital Bringing innovations to patients

Thuja Capital Healthcare Seed Fund I. Thuja Capital Healthcare Seed Fund II. You are here Thuja Capital. Why work with Thuja Capital? Why invest in a Thuja Capital fund? Our partners and network.

WHAT DOES VALNEVA.COM LOOK LIKE?

Desktop Screenshot of valneva.com Mobile Screenshot of valneva.com Tablet Screenshot of valneva.com

CONTACTS

INTERCELL AG

Stefan Tautscher

Campus-Vienna-Biocenter 3

Wien, 1030

AT

INTERCELL AG

Stefan Tautscher

Campus-Vienna-Biocenter 3

Wien, 1030

AT

A1 Telekom Austria AG

Domain Admin

Fadingerstrasse 6

Linz, AT, 4020

AT

VALNEVA.COM HOST

We diagnosed that a lone root page on valneva.com took seven hundred and nineteen milliseconds to download. Our web crawlers could not discover a SSL certificate, so therefore our parsers consider valneva.com not secure.
Load time
0.719 seconds
SSL
NOT SECURE
Internet Address
217.26.52.50

NAME SERVERS

ns4.intercell.com
ns5.intercell.com

SERVER OPERATING SYSTEM

I observed that this domain is operating the Apache/2.2.31 (FreeBSD) os.

TITLE

Valneva, a European Biotech Leader in Vaccines and Antibodies

DESCRIPTION

We are a biotech company in infectious diseases with two marketed products. Valneva covers the full value chain from bench to market. Vaccines against Japanese encephalitis and Cholera.

CONTENT

This domain had the following in the homepage, "We are a biotech company in." Our analyzers observed that the web page stated " A leading pure play vaccine biotech company." The Website also stated " Mdash; July 23, 2015. Valneva and PaxVax Enter into Marketing and Distribution Agreement. News, June 22, 2015. Valneva takes direct control over Marketing and Distribution of IXIARO. To increase margin and profitability." The website's header had valneva as the most important keyword. It was followed by japanese encephalitis, biotech, and biotechnology which isn't as highly ranked as valneva. The next words the site uses is vaccines. antibodies was also included and will not be understood by search crawlers.

OTHER WEB SITES

Awesome awesomeness is awesome

Loïc Arnaud is a French visual artist based in Dijon. After graduating from Ecole Supérieure des Beaux Arts. In Toulouse in 1997, he has worked as art carpenter for 10 years. He resumed his artistic production in 2009 and started an epic tale of the history of the 20th century that mixes with the mythological references and his personal history. It attempts to present the journey of a man through his day. Today, I no longer produc.

Valney Ribeiro

A hora do povo! TUR DE DIVULGAÇÃO COM ALCIMAR MONTEIRO. NATAL LIGHT 2010- A MAIOR FESTA DE NATAL DA BAHIA. O que você Procura? Prog A Hora do Povo.

Coffins and urns production Valnico.it

A leader in the production of coffins and urns. Valnico announces great novelties for Tanexpo 2012. Paolo Recanatini is a young and dynamic enterprising businessman who leads Valnico Group. Online the new website Valnico. On Friday our new website will be available with our new updated catalogue of urns, coffins and accessories. Our coffins are available in a wide range of inlayed and carved models. Tanexpo 2014 is coming! 8220;Certifica.

Home - Valerie Nieman

Reading at the Piccolo Spoleto Festival in Charleston, SC, May 2015. Valerie Nieman is a novelist and poet whose work draws on her life in Appalachia and the South. Her second poetry collection, Hotel Worthy,. Is newly published by Press 53, which also published her debut collection, Wake Wake Wake. Her poetry has been honored with the Greg Grummer, Byron Herbert Reece, and Nazim Hikmet prizes. Her most recent novel, Blood Clay,. Her 1988 novel Neena Gathering. Poems of love, loss, and survival.